{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antiaggregatory activity", "flavonoids", "flow cyto metry", "lipophilicity", "platelets"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31639087", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2478/acph-2019-0040"], "Journal": {"ISSN": "1846-9558", "JournalIssue": {"Volume": "69", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "01"}}, "Title": "Acta pharmaceutica (Zagreb, Croatia)", "ISOAbbreviation": "Acta Pharm"}, "ArticleTitle": "Influence of flavonoids' lipophilicity on platelet aggregation.", "Pagination": {"StartPage": "607", "EndPage": "619", "MedlinePgn": "607-619"}, "Abstract": {"AbstractText": ["Flavonoids are natural polyphenolic compounds present in a wide spectrum of plants that have a beneficial effect on human health. In the context of cardiovascular diseases related to plaque and thrombus formation, flavonoids exhibit an anti-aggregatory effect. Previously, it has been reported that all tested flavonoids exhibit an antiaggregatory effect on platelet aggregation when measured by impedance aggregometry on whole blood, in the test of aggregation induced by adenosine diphosphate (ADP). As not all flavonoids have the same targets within signaling pathways, an assumption of a common non-specific mechanism related to lipophilicity is to be considered. To test this hypothesis, reverse-phase thin layer chromatography was used to assess the lipophilicity of flavonoids; impedance aggregometry was used for testing of platelet aggregation and flow cytometry to monitor the influence of flavonoids on platelet activation. Lipophilicity analysis showed a highly negative correlation of logP and MINaAC for groups of flavones and flavanones. As determined by flow cytometry, the exposition of receptors necessary for the promotion of platelet activation and primary clot formation was diminished, i.e., lowered expression of the activated form of integrin \u03b1IIb\u03b23 was observed in the presence of flavanone. Platelet membrane stabilization by flavonoids as a mechanism of antiaggregatory effect has been supported by impedance aggregometry experiments when specific inhibitors of platelet aggregation signaling pathways (U73122, indomethacin, verapamil) were used in the presence of a weak (ADP) and a strong (TRAP-6) agonist of aggregation. While individual flavonoids can have specific targets within aggregation signaling pathways, all flavonoids share a common non-specific mechanism of platelet aggregation inhibition related to their lipophilicity and membrane stabilization that, to some extent, contributes to their antiaggregatory effect."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Croatian Institute of Transfusion Medicine, HR-10000Zagreb, Croatia."}], "LastName": "Babi\u0107", "ForeName": "Ivana", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal ChemistryHR-10000Zagreb, Croatia."}], "LastName": "Boji\u0107", "ForeName": "Mirza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical BotanyHR-10000Zagreb, Croatia."}], "LastName": "Male\u0161", "ForeName": "\u017deljan", "Initials": "\u017d"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Clinical Chemistry and Haematology, HR-10000ZagrebCroatia."}, {"Identifier": [], "Affiliation": "University Hospital Centre Zagreb, Department of Laboratory DiagnosticsHR-10000Zagreb, Croatia."}], "LastName": "Zadro", "ForeName": "Renata", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Croatian Institute of Transfusion Medicine, HR-10000Zagreb, Croatia."}], "LastName": "Goj\u010deta", "ForeName": "Koraljka", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical BotanyHR-10000Zagreb, Croatia."}], "LastName": "Duka", "ForeName": "Ivan", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal ChemistryHR-10000Zagreb, Croatia."}], "LastName": "Rimac", "ForeName": "Hrvoje", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Croatian Institute of Transfusion Medicine, HR-10000Zagreb, Croatia."}], "LastName": "Juki\u0107", "ForeName": "Irena", "Initials": "I"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Acta Pharm", "NlmUniqueID": "9303678", "ISSNLinking": "1330-0075"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Estrenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrrolidinones"}, {"RegistryNumber": "112648-68-7", "NameOfSubstance": "1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione"}, {"RegistryNumber": "CJ0O37KU29", "NameOfSubstance": "Verapamil"}, {"RegistryNumber": "XXE1CET956", "NameOfSubstance": "Indomethacin"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Blood Platelets"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Estrenes"}, {"QualifierName": ["physiology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Indomethacin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Platelet Aggregation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pyrrolidinones"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Verapamil"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "1. P. Knekt, R. Jarvinen, A. Reunanen and J. Maatela, Flavonoid intake and coronary mortality in Finland: a cohort study, Brit. Med. J.312 (1996) 478\u2013481; https://doi.org/10.1136/bmj.312.7029.47810.1136/bmj.312.7029.47823499218597679"}, {"Citation": "2. M. L. McCullough, J. J. Peterson, R. Patel, P. F. Jacques, R. Shah and J. T. Dwyer, Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults, Am. J. Clin. Nutr.95 (2012) 454\u2013464; https://doi.org/10.3945/ajcn.111.01663410.3945/ajcn.111.016634326007222218162"}, {"Citation": "3. M. L. Liang, X. W. Da, A. D. He, G. Q. Yao, W. Xie, G. Liu, J. Z. Xiang and Z. Y. Ming, Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function, Sci. Rep.5 (2015) 11142 (11 pages); https://doi.org/10.1038/srep1114210.1038/srep11142446191926059557"}, {"Citation": "4. Y. Wang, J. Tang, H. Zhu, X. Jiang, J. Liu, W. Xu, H. Ma, Q. Feng, J. Wu, M. Zhao and S. Peng, Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis, Int. J. Nanomed.10 (2015) 6905\u20136918; https://doi.org/10.2147/IJN.S9131610.2147/IJN.S91316463956326604756"}, {"Citation": "5. S. Vaiyapuri, H. Roweth, M. S. Ali, A. J. Unsworth, A. R. Stainer, G. D. Flora, M. Crescente, C. I. Jones, L. A. Moraes and J. M. Gibbins, Pharmacological actions of nobiletin in the modulation of platelet function, Br. J. Pharmacol. 172 (2015) 4133\u20134145; https://doi.org/10.1111/bph.1319110.1111/bph.13191454361825988959"}, {"Citation": "6. E. S. Park, Y. Lim, S. H. Lee, B. M. Kwon, H. S. Yoo, J. T. Hong and Y. P. Yun, Antiplatelet activity of obovatol, a biphenolic component of Magnolia obovata, in rat arterial thrombosis and rabbit platelet aggregation, J. Atheroscler. Thromb. 18 (2011) 659\u2013669; https://doi.org/10.5551/jat.742710.5551/jat.742721512279"}, {"Citation": "7. Y. R. Jin, X. H. Han, Y. H. Zhang, J. J. Lee, Y. Lim, J. H. Chung and Y. P. Yun, Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity, Atherosclerosis194 (2007) 144\u2013152; https://doi.org/10.1016/j.atherosclerosis.2006.10.01110.1016/j.atherosclerosis.2006.10.01117092506"}, {"Citation": "8. P. Pignatelli, F. M. Pulcinelli, A. Celestini, L. Lenti, A. Ghiselli, P. P. Gazzaniga and F. Violi, The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide, Am. J. Clin. Nutr. 72 (2000) 1150\u20131155; https://doi.org/10.1093/ajcn/72.5.115010.1093/ajcn/72.5.115011063442"}, {"Citation": "9. A. B. Hendrich, Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds, Acta. Pharmacol. Sin. 27 (2006) 27\u201340; https://doi.org/10.1111/j.1745-7254.2006.00238.x10.1111/j.1745-7254.2006.00238.x16364208"}, {"Citation": "10. P. I. Oteiza, A. G. Erlejman, S. V. Verstraeten, C. L. Keen and C. G. Fraga, Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Dev. Immunol. 12 (2005) 19\u201325; https://doi.org/10.1080/1044667041000172216810.1080/10446670410001722168227071715712595"}, {"Citation": "11. T. Lhermusier, H. Chap and B. Payrastre, Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome, J. Thromb. Haemost. 9 (2011) 1883\u20131891; https://doi.org/10.1111/j.1538-7836.2011.04478.x10.1111/j.1538-7836.2011.04478.x"}, {"Citation": "12. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 46 (2001) 3\u201326; https://doi.org/10.1016/S0169-409X(00)00129-010.1016/S0169-409X(00)00129-0"}, {"Citation": "13. G. L. Biagi, A. M. Barbaro, O. Gandolfi, M. C. Guerra and G. Cantelli-Forti, Rm values of steroids as an expression of their lipophilic character in structure-activity studies, J. Med. Chem. 18 (1975) 873\u2013883; https://doi.org/10.1021/jm00243a00310.1021/jm00243a003"}, {"Citation": "14. E. K\u0142osi\u0144ska-Szmur\u0142o, F. A. Pluci\u0144ski, M. Grudzie\u0144, K. Betlejewska-Kielak, J. Biernacka and A. P. Mazurek, Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability, J. Biol. Phys.40 (2014) 335\u2013345; https://doi.org/10.1007/s10867-014-9354-z10.1007/s10867-014-9354-z"}, {"Citation": "15. B. J. Bennion, N. A. Be, M. W. McNerney, V. Lao, E. M. Carlson, C. A. Valdez, M. A. Malfatti, H. A. Enright, T. H. Nguyen, F. C. Lightstone and T. S. Carpenter, Predicting a drug\u2019s membrane permeability: A computational model validated with in vitro permeability assay data, J. Phys. Chem. B.121 (2017) 5228\u20135237; https://doi.org/10.1021/acs.jpcb.7b0291410.1021/acs.jpcb.7b02914"}, {"Citation": "16. A. Daina, O. Michielin and V. Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017) 42717 (13 pages); https://doi.org/10.1038/srep4271710.1038/srep42717"}, {"Citation": "17. M. Boji\u0107, \u017d. Debeljak, M. Tomi\u010di\u0107, M. Medi\u0107-\u0160ari\u0107 and S. Tomi\u0107, Evaluation of antiaggregatory activity of flavonoid aglycone series, Nutrition J. 10 (2011) 73 (8 pages); https://doi.org/10.1186/1475-2891-10-7310.1186/1475-2891-10-73"}, {"Citation": "18. A. Brocchieri, L. Pacchiarini, A. Saporiti and G. Grignani, In vitro effect of verapamil on platelet activation induced by ADP, collagen or thrombin, Platelets6 (1995) 195\u2013199; https://doi.org/10.3109/0953710950907845410.3109/09537109509078454"}, {"Citation": "19. S. A. Saeed, H. Rasheed, F. A. Fecto, M. I. Achakzai, R. Ali, J. D. Connor and A. U. Gilani, Signalling mechanisms mediated by G-protein coupled receptors in human platelets, Acta Pharmacol. Sin. 25 (2004) 887\u2013889."}, {"Citation": "20. J. W. Heemskerk, R. W. Farndale and S. O. Sage, Effects of U73122 and U73343 on human platelet calcium signalling and protein tyrosine phosphorylation, Biochim. Biophys. Acta1355 (1997) 81\u201388; https://doi.org/10.1016/S0167-4889(96)00113-910.1016/S0167-4889(96)00113-9"}, {"Citation": "21. T. Wu, M. He, X. Zang, X. Zhou, T. Qiu, S. Pan and X. Xu, A structure-activity relationship study of flavonoids as inhibitors of E. coli by membrane interaction effect, Biochim. Biophys. Acta1828 (2013) 2751\u20132756; https://doi.org/10.1016/j.bbamem.2013.07.02910.1016/j.bbamem.2013.07.02923938956"}, {"Citation": "22. M. Shichijo, N. Yamamoto, H. Tsujishita, M. Kimata, H. Nagai and T. Kokubo, Inhibition of syk activity and degranulation of human mast cells by flavonoids, Biol. Pharm. Bull. 26 (2003) 1685\u20131690; https://doi.org/10.1248/bpb.26.168510.1248/bpb.26.1685"}, {"Citation": "23. A. Oliveira Filho, H. M. Fernandes, T. J. C. Assis, D. R. Meireles, O. Edeltrudes, E. Lima and H. L. F. P\u00eassoa, Pharmacological and toxicological analysis of flavonoid 5,7,4\u2019-trimethoxyflavone: An in silico approach, IJPPR7 (2015) 431\u2013434."}, {"Citation": "24. C. van Dijk, A. J. Driessen and K. Recourt, The uncoupling efficiency and affinity of flavonoids for vesicles, Biochem. Pharmacol. 60 (2000) 1593\u20131600; https://doi.org/10.1016/S0006-2952(00)00488-310.1016/S0006-2952(00)00488-3"}, {"Citation": "25. A. Arora, T. M. Byrem, M. G. Nair and G. M. Strasburg, Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids, Arch. Biochem. Biophys. 373 (2000) 102\u2013109; https://doi.org/10.1006/abbi.1999.152510.1006/abbi.1999.1525"}, {"Citation": "26. S. Kitagawa, M. Orinaka and H. Hirata, Depth-dependent change in membrane fluidity by phenolic compounds in bovine platelets and its relationship with their effects on aggregation and adenylate cyclase activity, Biochim. Biophys. Acta1179 (1993) 277\u2013282; https://doi.org/10.1016/0167-4889(93)90083-210.1016/0167-4889(93)90083-2"}, {"Citation": "27. N. Vlasic, M. S. Medow, S. M. Schwarz, K. A. Pritchard and M. B. Stemerman, Lipid fluidity modulates platelet aggregation and agglutination in vitro, Life Sci.53 (1993) 1053\u20131060; https://doi.org/10.1016/0024-3205(93)90258-510.1016/0024-3205(93)90258-5"}, {"Citation": "28. K. Yoshida, S. Nagatoishi, D. Kuroda, N. Suzuki, T. Murata and K. Tsumoto, Phospholipid membrane fluidity alters ligand binding activity of a G protein-coupled receptor by shifting the conformational equilibrium, Biochemistry58 (2019) 504\u2013508; https://doi.org/10.1021/acs.biochem.8b01194 (in press)10.1021/acs.biochem.8b0119430618239"}, {"Citation": "29. M. Boji\u0107, \u017d. Debeljak, M. Medi\u0107-\u0160ari\u0107 and M. Tomi\u010di\u0107, Interference of selected flavonoid aglycons in platelet aggregation assay, Clin. Chem. Lab. Med.50 (2012) 1403\u20131408; https://doi.org/10.1515/cclm-2011-096010.1515/cclm-2011-096022868805"}, {"Citation": "30. L. M. Ostertag, N. O\u2019Kennedy, G. W. Horgan, P. A. Kroon, G. G. Duthie and B. de Roos, In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations, Mol. Nutr. Food Res. 55 (2011) 1624\u20131636; https://doi.org/10.1002/mnfr.20110013510.1002/mnfr.20110013521898791"}, {"Citation": "31. S. Vaiyapuri, M. S. Ali, L. A. Moraes, T. Sage, K. R. Lewis, C. I. Jones and J. M. Gibbins, Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signalling, Arterioscler. Thromb. Vasc. Biol. 33 (2013) 2740\u20132749; https://doi.org/10.1161/ATVBAHA.113.30198810.1161/ATVBAHA.113.30198824135020"}, {"Citation": "32. T. Gremmel, R. Koppensteiner and S. Panzer, Comparison of aggregometry with flow cytometry for the assessment of agonists\u2019-induced platelet reactivity in patients on dual antiplatelet therapy, PLoS One10 (2015) e0129666 (13 pages); https://doi.org/10.1371/journal.pone.012966610.1371/journal.pone.0129666446116426058047"}, {"Citation": "33. K. Koltai, G. Kesmarky, G. Feher, A. Tibold and K. Toth, Platelet aggregometry testing: Molecular mechanisms, techniques and clinical implications, Int. J. Mol. Sci.18 (2017) 1803 (21 pages); https://doi.org/10.3390/ijms1808180310.3390/ijms18081803557819028820484"}], "Title": "REFERENCES"}], "History": [{"Year": "2019", "Month": "7", "Day": "23"}, {"Year": "2019", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31639087", "10.2478/acph-2019-0040", "acph-2019-0040"]}}]}